Natalie Sacks's Insider Trades & SAST Disclosures

Natalie Sacks's most recent trade in Caribou Biosciences Inc was a trade of 45,000 Option to purchase Common Stock done . Disclosure was reported to the exchange on Feb. 20, 2026.

Share

Note

This is a custom search result for pattern Natalie Sacks.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Caribou Biosciences Inc High Gain High Volume	Natalie Sacks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2026	45,000	45,000	-		-	Option to purchase Common Stock
Caribou Biosciences Inc High Gain High Volume	Natalie Sacks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2025	40,500	40,500	-		-	Option to purchase Common Stock
Caribou Biosciences Inc High Gain High Volume	Natalie Sacks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Feb 2024	39,500	39,500	-		-	Option to purchase Common Stock
Caribou Biosciences Inc High Gain High Volume	Natalie Sacks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2023	21,500	21,500	-		-	Option to purchase Common Stock
Zymeworks BC Inc	Natalie Sacks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Dec 2022	25,000	25,000	-		-	Stock Option (Right to Buy)
Harpoon Therapeutics Inc	Natalie Sacks	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2022	155,000	155,000	-		-	Employee Stock Option (right to buy)
Caribou Biosciences Inc High Gain High Volume	Natalie Sacks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Dec 2021	27,500	27,500	-		-	Option to purchase Common Stock
Harpoon Therapeutics Inc	Natalie Sacks	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2021	155,000	155,000	-		-	Employee Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades